tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
4D Molecular Therapeutics Holds Annual Stockholders Meeting
PremiumCompany Announcements4D Molecular Therapeutics Holds Annual Stockholders Meeting
1M ago
Promising Potential and Financial Stability Drive Buy Rating for 4D Molecular Therapeutics
Premium
Ratings
Promising Potential and Financial Stability Drive Buy Rating for 4D Molecular Therapeutics
3M ago
Promising Advancements in 4D Molecular Therapeutics’ Gene Therapy Programs Drive Buy Rating
Premium
Ratings
Promising Advancements in 4D Molecular Therapeutics’ Gene Therapy Programs Drive Buy Rating
3M ago
4D Molecular sees cash, equivalents funding planned operations into 2028
PremiumThe Fly4D Molecular sees cash, equivalents funding planned operations into 2028
3M ago
4D Molecular announces RMAT designation granted by FDA for 4D-150 for DME
Premium
The Fly
4D Molecular announces RMAT designation granted by FDA for 4D-150 for DME
3M ago
Biotech stocks slide as Marks resignation seen being negative for sector
Premium
The Fly
Biotech stocks slide as Marks resignation seen being negative for sector
4M ago
4D Molecular price target lowered to $35 from $39 at RBC Capital
PremiumThe Fly4D Molecular price target lowered to $35 from $39 at RBC Capital
5M ago
Promising Developments in 4D Molecular Therapeutics’ Gene Therapy Program Justify Buy Rating
Premium
Ratings
Promising Developments in 4D Molecular Therapeutics’ Gene Therapy Program Justify Buy Rating
5M ago
4D Molecular Therapeutics Reports Strong Clinical Progress and Financial Position
Premium
Company Announcements
4D Molecular Therapeutics Reports Strong Clinical Progress and Financial Position
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100